Condition / Treatment sleep

Insomnia and Cognitive Behavioral Therapy

Insomnia is a common sleep disorder marked by difficulty initiating or maintaining sleep and daytime impairment, affecting roughly 10% of adults chronically. Cognitive Behavioral Therapy for Insomnia (CBT-I) is the leading nonpharmacologic treatment and is recommended as first-line therapy by major medical bodies. CBT-I targets the perpetuating factors that maintain insomnia—maladaptive sleep behaviors and distorted cognitions—using a structured program typically comprising stimulus control, sleep restriction (or time-in-bed compression), cognitive therapy, relaxation strategies, and tailored sleep hygiene and circadian guidance. Robust evidence from clinical guidelines and meta-analyses shows CBT-I produces clinically meaningful improvements in sleep onset latency, wake after sleep onset, sleep efficiency, and insomnia severity, with benefits that persist months to years after treatment ends. These outcomes are at least comparable to hypnotic medications in the short term and are more durable long term, with fewer adverse effects. Delivery formats include individual, group, and validated digital programs, improving access in primary care and populations with limited sleep-specialty services. CBT-I is also effective when insomnia is comorbid with depression, anxiety, chronic pain, cancer, and medical conditions, though concurrent management of primary sleep disorders (like obstructive sleep apnea or restless legs syndrome) and circadian rhythm disorders increases success. Factors that heighten insomnia risk—hyperarousal, high sleep reactivity, irregular schedules, and unhelpful beliefs about sleep—also predict who stands to benefit from CBT-I, because therapy directly targets these mechanisms. In Eastern medicine frameworks such as Traditional Chinese Medicine (TCM), insomnia reflects disharmonies affecting the Heart (Shen), Liver, and Spleen systems, with excess heat, yin deficiency, or phlegm-stagnation as common patterns. Behavioral guidance akin to CBT’s sleep-h

Updated March 14, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Shared Risk Factors

Hyperarousal and anxiety sensitivity

Strong Evidence

Physiological and cognitive hyperarousal predispose to and maintain insomnia; worry and rumination amplify sleep disturbance.

Increases risk and severity of chronic insomnia.
Predicts good CBT-I targets and response when cognitive and relaxation components are emphasized.

Maladaptive sleep behaviors and beliefs

Strong Evidence

Extended time in bed, irregular schedules, napping, clock-watching, and catastrophic sleep beliefs perpetuate insomnia.

Maintain insomnia via conditioned arousal and sleep fragmentation.
Are primary mechanisms CBT-I modifies (stimulus control, sleep restriction, cognitive restructuring).

Circadian disruption (shift work, evening chronotype, irregular timing)

Moderate Evidence

Misaligned sleep-wake timing impairs sleep initiation and maintenance.

Raises risk of insomnia symptoms and daytime dysfunction.
Requires integration of circadian modules (timed light, melatonin, anchor wake times) within CBT-I.

Comorbid mood and anxiety disorders

Strong Evidence

High bidirectional comorbidity with depression, generalized anxiety, and PTSD.

Increases prevalence, severity, and chronicity of insomnia.
CBT-I remains effective; may also improve mood/anxiety, but often needs parallel disorder-specific care.

Substance use (caffeine, alcohol, nicotine)

Strong Evidence

Stimulants and evening alcohol disrupt sleep architecture; nicotine increases arousal.

Aggravates sleep initiation/maintenance problems.
Addressed within CBT-I; heavy dependence may reduce adherence and outcomes unless treated.

Chronic pain and medical illness

Moderate Evidence

Pain and illness-related awakenings perpetuate conditioned insomnia.

Commonly co-occurs with insomnia and worsens sleep continuity.
CBT-I effective with tailoring (pacing, relaxation); coordinate analgesia and medical management.

High sleep reactivity (trait)

Moderate Evidence

Greater tendency to develop insomnia after stressors (3P model).

Predicts onset and persistence of insomnia following precipitating events.
Identifies candidates likely to benefit from CBT-I’s deconditioning and cognitive elements.

Access, motivation, and digital literacy

Emerging Research

Structural and personal factors influence who receives and completes therapy.

Delays care and prolongs insomnia course.
Impacts uptake and adherence; digital CBT-I can mitigate access barriers if literacy is adequate.

Comorbidity Data

Prevalence

Chronic insomnia disorder affects about 10% of adults; 30–50% report subthreshold symptoms annually. Psychiatric comorbidity is common (depression/anxiety in ~40–60% of chronic insomnia).

Mechanistic Link

CBT-I targets perpetuating mechanisms in Spielman’s 3P model—conditioned arousal, irregular sleep schedules, and maladaptive cognitions—thereby improving sleep initiation and maintenance and reducing daytime impairment.

Clinical Implications

Guidelines recommend CBT-I as first-line for chronic insomnia, including with common comorbidities. Screen and treat primary sleep disorders (e.g., obstructive sleep apnea, restless legs) and address circadian misalignment to optimize outcomes. Pharmacotherapy can be reserved for short-term adjunctive use when rapid symptom relief is needed or when CBT-I access is limited.

Sources (3)
  1. Qaseem A et al. Ann Intern Med. 2016;165:125-133.
  2. Edinger JD et al. J Clin Sleep Med. 2021;17(2):255-262.
  3. Spielman AJ et al. Psychiatr Clin North Am. 1987;10(4):541-553.

Overlapping Treatments

Stimulus control therapy

Strong Evidence
Benefits for Insomnia

Reduces conditioned arousal and sleep-onset latency; improves sleep efficiency.

Benefits for Cognitive Behavioral Therapy

Core CBT-I component; adherence strongly predicts outcomes.

Sleep restriction/time-in-bed compression

Strong Evidence
Benefits for Insomnia

Consolidates sleep and increases homeostatic drive; reduces wake after sleep onset.

Benefits for Cognitive Behavioral Therapy

Foundational CBT-I element producing large effect sizes.

Monitor for transient daytime sleepiness; use caution in bipolar disorder, seizure risk, or safety-sensitive occupations.

Cognitive therapy (restructuring, paradoxical intention)

Strong Evidence
Benefits for Insomnia

Reduces worry, catastrophic beliefs, and performance anxiety about sleep.

Benefits for Cognitive Behavioral Therapy

Central CBT-I pillar; synergistic with behavioral components.

Relaxation training (PMR, diaphragmatic breathing)

Moderate Evidence
Benefits for Insomnia

Decreases physiological arousal, aiding sleep initiation.

Benefits for Cognitive Behavioral Therapy

Adjunct within CBT-I; enhances acceptability and adherence.

Mindfulness-based therapy for insomnia (MBTI)/meditation

Moderate Evidence
Benefits for Insomnia

Improves insomnia severity and sleep quality, especially with rumination.

Benefits for Cognitive Behavioral Therapy

Integrates well with CBT-I or serves as an alternative when cognitive work is preferred.

Effects may be slightly smaller than full CBT-I; best with structured protocols.

Exercise (moderate aerobic/resistance)

Moderate Evidence
Benefits for Insomnia

Improves sleep quality and reduces insomnia symptoms over weeks.

Benefits for Cognitive Behavioral Therapy

Lifestyle adjunct that can augment CBT-I outcomes and mood.

Avoid vigorous activity close to bedtime in sensitive individuals.

Circadian interventions (morning bright light, timed melatonin for DSWPD)

Moderate Evidence
Benefits for Insomnia

Corrects phase delay/misalignment contributing to insomnia complaints.

Benefits for Cognitive Behavioral Therapy

Common CBT-I adjunct when circadian factors are present.

Melatonin primarily benefits circadian disorders; modest effect in primary chronic insomnia.

Medical Perspectives

Western Perspective

CBT-I is the evidence-based first-line therapy for chronic insomnia, outperforming or matching hypnotics in the short term and offering superior durability and safety. It directly addresses behavioral and cognitive perpetuating factors and can be delivered in various formats, including validated digital platforms that expand access.

Key Insights

  • Strong and durable improvements in insomnia severity, sleep continuity, and daytime function.
  • Effective across age groups and in common comorbidities (depression, anxiety, chronic pain, cancer).
  • Digital CBT-I shows clinically meaningful benefits and cost-effectiveness in primary care.
  • Adjunctive focus on circadian alignment and screening for OSA/RLS enhances outcomes.
  • Side effects are minimal; transient sleepiness during restriction is the most common.

Treatments

  • Stimulus control
  • Sleep restriction/time-in-bed compression
  • Cognitive restructuring and paradoxical intention
  • Relaxation training
  • Sleep hygiene and circadian stabilization
  • Digital CBT-I (online/app-based)
Evidence: Strong Evidence

Sources

  • Edinger JD et al. J Clin Sleep Med. 2021;17(2):255-262.
  • Trauer JL et al. Ann Intern Med. 2015;163:191-204.
  • van Straten A et al. Sleep Med Rev. 2018;38:3-16.
  • Qaseem A et al. Ann Intern Med. 2016;165:125-133.
  • NICE. Sleepio recommended for primary care (2022).
  • Zachariae R et al. Sleep Med Rev. 2016;30:1-10.

Eastern Perspective

In Traditional Chinese Medicine, insomnia reflects disharmonies affecting the Heart (Shen), Liver, and Spleen systems, with patterns such as yin deficiency with heat, Liver qi stagnation, or phlegm-heat disturbing the mind. Behavioral guidance (yangsheng), mindfulness/qigong, acupuncture, and classic herbal formulas aim to calm the Shen and restore balance. These approaches conceptually align with CBT-I’s goals of reducing hyperarousal and reconditioning sleep but work through different explanatory frameworks.

Key Insights

  • Acupuncture and acupressure may improve sleep quality and insomnia severity versus waitlist or medication, though study quality is variable.
  • Mindfulness, Tai Chi, and qigong reduce arousal and improve subjective sleep, offering complementary tools for worry and somatic tension.
  • Herbal formulas (e.g., Suan Zao Ren Tang, Gan Mai Da Zao Tang) are traditionally used; evidence is mixed and requires quality-controlled products and monitoring for interactions.
  • Combining mindfulness or acupuncture with CBT-I may address both cognitive and somatic arousal in select patients.

Treatments

  • Acupuncture/acupressure (e.g., HT7, SP6, Anmian points)
  • Mindfulness meditation and MBTI
  • Tai Chi and qigong
  • Herbal formulas such as Suan Zao Ren Tang or Gan Mai Da Zao Tang (with professional guidance)
Evidence: Emerging Research

Sources

  • Cheuk DKL et al. Cochrane Database Syst Rev. 2012;(9):CD005472.
  • Zhang Y et al. Sleep Med. 2020;67:209-222.
  • Black DS et al. JAMA Intern Med. 2015;175(4):494-501.
  • Li F et al. Sleep. 2004;27(1):101-108.
  • Ong JC et al. Sleep. 2014;37(9):1553-1563.

Evidence Ratings

CBT-I is first-line therapy for chronic insomnia in adults.

Edinger JD et al. J Clin Sleep Med. 2021;17(2):255-262; Qaseem A et al. Ann Intern Med. 2016;165:125-133.

Strong Evidence

CBT-I yields durable improvements in sleep and daytime function with minimal adverse effects.

Trauer JL et al. Ann Intern Med. 2015;163:191-204; van Straten A et al. Sleep Med Rev. 2018;38:3-16.

Strong Evidence

Digital CBT-I is effective and scalable in primary care and community settings.

Zachariae R et al. Sleep Med Rev. 2016;30:1-10; NICE 2022 Sleepio recommendation.

Moderate Evidence

CBT-I improves insomnia with comorbid depression and anxiety and may yield secondary mood benefits.

Edinger JD et al. J Clin Sleep Med. 2021;17(2):255-262.

Moderate Evidence

Mindfulness-based approaches and Tai Chi can improve sleep quality and insomnia symptoms.

Black DS et al. JAMA Intern Med. 2015;175(4):494-501; Li F et al. Sleep. 2004;27(1):101-108.

Moderate Evidence

Acupuncture may benefit insomnia, but evidence quality and consistency vary.

Cheuk DKL et al. Cochrane Database Syst Rev. 2012;(9):CD005472; Zhang Y et al. Sleep Med. 2020;67:209-222.

Emerging Research

Western Medicine Perspective

CBT-I operationalizes a mechanistic understanding of insomnia rooted in Spielman’s 3P model, focusing on the learned associations and maladaptive cognitions that keep insomnia alive after the initial trigger subsides. Stimulus control rebuilds the bed–sleep link; sleep restriction leverages homeostatic drive to consolidate sleep; cognitive therapy reduces sleep-related worry and catastrophic thinking; relaxation dampens physiological arousal; sleep hygiene and circadian stabilization support consistency. Meta-analyses and clinical guidelines consistently show moderate-to-large improvements in insomnia severity, sleep continuity metrics, and daytime functioning, with benefits sustained long after treatment. Digital CBT-I broadens access and is endorsed in some health systems as cost-saving. In practice, clinicians should first rule out or co-manage OSA, restless legs, and circadian rhythm disorders, and tailor CBT-I in the context of comorbid pain, mood, or anxiety disorders. Short-term hypnotics can be considered when immediate relief is necessary or access to CBT-I is delayed, but long-term reliance is discouraged due to tolerance, dependence, and adverse effects, whereas CBT-I builds durable self-management skills. Monitoring for transient daytime sleepiness during sleep restriction and providing safety guidance (e.g., driving) are key. Outcome tracking with validated scales (e.g., ISI) and sleep diaries supports adherence and shared decision-making.

Eastern Medicine Perspective

From an Eastern perspective, insomnia arises when the balance of yin–yang and the calmness of Shen are disrupted by factors such as emotional strain (Liver qi stagnation), overthinking (Spleen deficiency), or yin deficiency with heat agitating the Heart. Treatment aims to nourish yin, clear heat, move qi, and calm the mind. Acupuncture protocols often target HT7, SP6, PC6, and Anmian to settle Shen and harmonize organ systems; Tai Chi and qigong gently reduce somatic tension and restore autonomic balance; mindfulness and breath practices cultivate nonreactivity to sleep-related thoughts. Herbal formulas like Suan Zao Ren Tang and Gan Mai Da Zao Tang are chosen according to pattern differentiation, though modern use should consider product quality and drug–herb interactions. Conceptually, these methods complement CBT-I by addressing hyperarousal and embodied tension while CBT-I restructures behavior and cognition. Evidence suggests mindfulness and Tai Chi can improve sleep quality and symptom severity, and acupuncture may help some patients, but methodological limitations and heterogeneity temper certainty. A pragmatic, integrative approach may pair CBT-I with mindfulness or acupuncture to address both cognitive-worry and somatic-arousal pathways, provided care is coordinated and safety (e.g., herb–drug interactions) is considered.

Sources
  1. Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262.
  2. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the ACP. Management of chronic insomnia disorder in adults: a clinical practice guideline. Ann Intern Med. 2016;165:125-133.
  3. Trauer JL, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163:191-204.
  4. van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018;38:3-16.
  5. Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered CBT for insomnia: a systematic review and meta-analysis. Sleep Med Rev. 2016;30:1-10.
  6. NICE (2022). NICE recommends Sleepio for insomnia in primary care (Medtech guidance/press release).
  7. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541-553.
  8. Black DS, O’Reilly GA, Olmstead R, Breen EC, Irwin MR. Mindfulness meditation and improvement in sleep quality. JAMA Intern Med. 2015;175(4):494-501.
  9. Li F, Fisher KJ, Harmer P, Irbe D, Tearse RG, Weimer C. Tai Chi and sleep quality in older adults: a randomized controlled trial. Sleep. 2004;27(1):101-108.
  10. Cheuk DKL, Yeung WF, Chung KF, Wong V. Acupuncture for insomnia. Cochrane Database Syst Rev. 2012;(9):CD005472.
  11. Zhang Y, Lin L, Li H, Hu Y, Tian L. Effects of acupuncture for primary insomnia: a systematic review and meta-analysis. Sleep Med. 2020;67:209-222.
  12. Ong JC, Shapiro SL, Manber R. Mindfulness-based therapy for insomnia (MBTI): a randomized controlled clinical trial. Sleep. 2014;37(9):1553-1563.

Related Topics

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.